California State Teachers Retirement System (CalSTRS)’s Monopar Therapeutics MNPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.5K Sell
247
-34
-12% -$2.05K ﹤0.01% 2567
2025
Q4
$18.3K Buy
281
+26
+10% +$2.12K ﹤0.01% 2554
2025
Q3
$20.8K Buy
255
+1
+0.4% +$45 ﹤0.01% 2544
2025
Q2
$9.09K Buy
+254
New +$9.22K ﹤0.01% 2770

Other funds holding MNPR

California State Teachers Retirement System (CalSTRS)'s MNPR Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Monopar Therapeutics (MNPR) stake by 12% in Q1 2026, selling an estimated $2.05K and leaving 247 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2567.

California State Teachers Retirement System (CalSTRS) first reported a position in MNPR in Q2 2025 and has held it in 4 quarters since. The position peaked at $20.8K in Q3 2025. 82 funds tracked by Wall St. Rank hold MNPR as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 247 shares of Monopar Therapeutics worth $13.5K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 34 Monopar Therapeutics shares in Q1 2026, an estimated $2.05K.
  • Monopar Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2567 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Monopar Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Monopar Therapeutics position peaked at $20.8K in Q3 2025.
  • 82 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.